Bone marrow plasminogen activator inhibitor-1 influences the development of obesity. - Wikidata - wikimedia - TriplyDB

Bone marrow plasminogen activator inhibitor-1 influences the development of obesity.

Bone marrow plasminogen activator inhibitor-1 influences the development of obesity.

http://www.wikidata.org/entity/Q51491433

about

Particulate matter-induced lung inflammation increases systemic levels of PAI-1 and activates coagulation through distinct mechanisms Characterization of human mesenchymal stem cell secretome at early steps of adipocyte and osteoblast differentiation.Characterization of a novel class of polyphenolic inhibitors of plasminogen activator inhibitor-1 Effect of photoperiod on the feline adipose transcriptome as assessed by RNA sequencing.Urokinase plasminogen activator induces pro-fibrotic/m2 phenotype in murine cardiac macrophages Deficiency of ACE2 in Bone-Marrow-Derived Cells Increases Expression of TNF-α in Adipose Stromal Cells and Augments Glucose Intolerance in Obese C57BL/6 Mice Fatty acid-induced production of plasminogen activator inhibitor-1 by adipose macrophages is greater in middle-aged versus younger adult participants.Gastric expression of plasminogen activator inhibitor (PAI)-1 is associated with hyperphagia and obesity in mice Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy Pima Indians.Novel Role of Endogenous Catalase in Macrophage Polarization in Adipose Tissue.Getting the message across: mechanisms of physiological cross talk by adipose tissue.Therapeutic potential of plasminogen activator inhibitor-1 inhibitors.Thrombin promotes diet-induced obesity through fibrin-driven inflammation.Plasminogen activator inhibitor links obesity and thrombotic cerebrovascular diseases: The roles of PAI-1 and obesity on stroke.Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with type 2 diabetes risk.Deficiency of plasminogen activator inhibitor-2 impairs nutritionally induced murine adipose tissue development.Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages.Adipose tissue macrophages: a piece of the PAI of metabolic syndrome.Dietary strawberry powder reduces blood glucose concentrations in obese and lean C57BL/6 mice, and selectively lowers plasma C-reactive protein in lean mice.PAI-1 Exacerbates White Adipose Tissue Dysfunction and Metabolic Dysregulation in High Fat Diet-Induced Obesity

P2860

Q27348345-7635AFB1-D525-41DC-984A-B380B4AAF76D Q33321325-BDBC70D6-CB9B-4BDA-ADE2-F7423B2FE292 Q33522880-9B9B1916-88EB-4A34-BB25-7C4B9A9AF23A Q33883437-DE504CC7-18E6-40EB-9763-14FD4015DC95 Q34639045-1CDF0B1E-C087-4596-804B-C6F8EECD272E Q35810634-2ED1B5A8-4958-48ED-A530-AF199BD4B5E0 Q36895081-6C2C2221-838C-4BE9-8153-563E1319A254 Q37049096-38C34AC1-CDF2-46B8-AFFA-C23B32121D06 Q37066894-82D0F7EE-FAB0-4F9D-A821-FAE9449AD688 Q37212642-2ED4E7E5-7B63-4A3E-B9A9-E76FF18C24E4 Q37405747-39C81130-B81D-4180-979A-82207E28E913 Q37775818-35095E20-9EC4-4A3C-BA93-2361BE0636D2 Q38665177-F09F11D3-63C7-4CAA-992F-1BC5C909C23F Q39220804-327C2040-6A51-4874-A280-69C54C00E66A Q42584438-1C6E6F99-AAD4-4464-B58E-CFAEC8D9DD4F Q42823293-0455EE17-5691-4E36-9559-E41893911479 Q43108135-2E291276-8A0C-4CD1-8DB9-93B8A00F6BCF Q43108137-257216C7-3665-4094-81E8-A603424A1DA2 Q46682226-C2C9767F-D70C-4EB3-A12B-B083348C95D1 Q57491570-04ED1EB5-FE05-435A-889A-A0DB49A6CA57

P2860

Bone marrow plasminogen activator inhibitor-1 influences the development of obesity.

http://www.wikidata.org/entity/Q51491433

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Bone marrow plasminogen activator inhibitor-1 influences the development of obesity.

@en

Bone marrow plasminogen activator inhibitor-1 influences the development of obesity.

@nl

type

label

Bone marrow plasminogen activator inhibitor-1 influences the development of obesity.

@en

Bone marrow plasminogen activator inhibitor-1 influences the development of obesity.

@nl

prefLabel

Bone marrow plasminogen activator inhibitor-1 influences the development of obesity.

@en

Bone marrow plasminogen activator inhibitor-1 influences the development of obesity.

@nl

P1433

Q51491433-9B0B74AF-B88A-44C3-818D-A98188B3B048

P1476

Q51491433-7E054DC2-BDD0-4E13-ACFE-0EA6EC9792BF

P2093

Q51491433-1ACA6284-AE9B-4AE2-9CA2-AC3A45B5A634

Q51491433-33B99D0D-9635-425E-B66C-CBA56795495B

Q51491433-3A7C850D-4D51-4790-BE76-CADE7143B29B

Q51491433-4A01D4F8-D5FE-432E-8744-A97863F87A69

Q51491433-6678F8A2-5A45-429F-898E-F247642BED3C

P2860

Q51491433-0CD3EFDE-3FB2-4009-9D58-D00729948A7D

Q51491433-1987BA41-A10D-4963-A2C0-59050FF081B0

Q51491433-20E98C8C-B3ED-4D8A-B447-8ADC74725A1B

Q51491433-3B07D742-9847-497C-8736-85D9F6254DA3

Q51491433-3D97D75A-BF30-4400-88EE-D1F5E0315278

Q51491433-41DC426E-ECAA-409C-9469-3E805D2ABF94

Q51491433-50130F75-04DE-4C4B-A75D-1A70397D22BE

Q51491433-5373A7DC-1598-4259-B04E-D536E6C711C7

Q51491433-59D9EE23-93CC-454E-916A-5DC4662450CF

Q51491433-6C5B1556-0ED5-4948-BAA1-EDA2EC340835

P304

Q51491433-49C503DD-C050-4C54-9A45-C641CC7A2628

P31

Q51491433-DB1665F7-5D93-4455-BA3F-F5799C46255C

P356

Q51491433-9D9639C6-8413-4A99-8D6A-848299F77C2A

P407

Q51491433-7DBEC7E2-0DFE-4C9E-B4C7-6B2B38E3E17A

P433

Q51491433-3E7E3294-A64B-44C2-8469-39E093AB4FB1

P478

Q51491433-8893BE09-2943-4292-A3E2-472650D628DC

P577

Q51491433-E5F1829C-74C8-481E-A2AE-3103DF26EC91

P698

Q51491433-9DA387A3-CE67-4039-A8AC-759114B50588

P921

Q51491433-1719AF8D-989E-42F2-9C7B-B84119240E8C

P356

P1433

Journal of Biological Chemistry

P1476

Bone marrow plasminogen activator inhibitor-1 influences the development of obesity.

@en

P2093

Bart M De Taeye

http://www.w3.org/2001/XMLSchema#string

Douglas E Vaughan

http://www.w3.org/2001/XMLSchema#string

Joseph W Covington

http://www.w3.org/2001/XMLSchema#string

Linda Gleaves

http://www.w3.org/2001/XMLSchema#string

Tatiana Novitskaya

http://www.w3.org/2001/XMLSchema#string

P2860

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Obesity is associated with macrophage accumulation in adipose tissue

The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans

Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization.

Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: implications for clinical trials.

Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture.

P304

32796-32805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M606214200

http://www.w3.org/2001/XMLSchema#string

P407

P433

43

http://www.w3.org/2001/XMLSchema#string

P478

281

http://www.w3.org/2001/XMLSchema#string

P577

2006-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16931518

http://www.w3.org/2001/XMLSchema#string

P921